License Your Genetically Modified (GM) Research Model

Licence agreement

Major technological breakthroughs in the genetic engineering field are usually subject to intellectual property (IP) rights, such as patents.

As a genetic engineering service company, we enter into agreements with the owners of such technologies to be a natural partner of the scientific community. That way, we can provide our academic, pharmaceutical, and biotechnological customers with an access to state-of-the-art and reliable research tools, through:

  • The creation of new genetically modified models with genOway
  • The acquisition of suitable rights for the use of models obtained from third parties with increased IP security

Each research project is different, and in that regard, the necessary technologies to generate the desired model can be various as well. Therefore, researchers may need to acquire specific rights relating to the used technologies, so that they can operate their GM models with no further encumbrance. Such suitable rights can vary depending on the following fields of use:

  • Basic research – Analysis of genes and their function or products
  • Biopharmaceutical research – Activities aimed at developing drugs, including but not limited to target validation and drug screening, e.g., mice expressing a druggable protein
  • Biologics engineering – Discovery and engineering of biologics molecules, e.g., humanized mouse models for human antibody development

For more information, feel free to contact us.


Frequently asked questions

Why are there patents?

Innovation is key. To accelerate innovation, it has been decided to disclose inventions, so that everyone can be inspired by them. However, it takes countless hours / years to come up with a useful and robust invention; conversely, it takes minutes / days to copy it. Patents help inventors to disclose their inventions and get temporary benefits from their investment.

What is a patent?

A legal title granted to the holder:

  • In countries for which the patent has been granted and maintained
  • For a limited time (up to 20 years)
  • In return for this protection, the holder has to disclose the invention to the public

Why do we have the licenses?

  • To use the inventions and reward their inventors
  • To gain a competitive advantage by acquiring exclusive licenses (meaning our competitors don't have any right to use those specific inventions without genOway's permission)

Are there infringements? By whom, clients, service providers?

Process patents usually cover the use of the precise technology specified in the claims of the patents as well as the holding, the using and the breeding of the models.

What are the consequences of infringements?

  • To be obliged to stop all uses of the invention and to pay for past uses
  • To have to destroy all material made with the use of the patent
  • To pay damages to the patent owner (or exclusive licensee)
  • To pay all costs of the lawsuit (at least US$ 10 million if in the US)
  • To have very deleterious publicity (information is public and infringer may be obliged to post it on its website

What are the advantages of acquiring a license?

Directly acquiring a fair license will certainly be cheaper, quicker and way more efficient for your organization than investing a great deal of time and resources to delay its decision. genOway is a service company; our mission is to provide solutions to our customers.

Most big biopharmaceutical are fully aware of the importance of the technologies such as Kin. Consequently, when your organization negotiates with these companies, freedom to use the models will be requested by these partners. Having acquired the right licenses will then be an asset.